Publication | Closed Access

Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the united states

Breast OncologyOncologyHealth EconomicsCancer ManagementOutcomes ResearchBreast CancerPharmacotherapyCancer TreatmentUnited StatesMedicineRadiation OncologyEarly-stage Breast CancerHealth Sciences